Growth Trajectories of Medication Adherence in Pediatric Organ Transplantation and Their Relationship to Posttransplant Health Outcomes

These findings underscore the dynamic and heterogeneous nature of adherence across pediatric transplant populations. MLVI-based trajectory modeling offers a promising avenue for early risk identification and could inform the development of electronic medical record-integrated alerts or personalized adherence interventions. Future research should integrate psychosocial variables and expand to multicenter samples for enhanced generalizability.